Riga Thomas J's Form 4 filing
Spectrum Pharmaceuticals Inc (SPPI) · filed Feb 1, 2023
- Accession no.
- 0000899243-23-003144
- Filed
- Feb 1, 2023
- Trade date
- Jan 30-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $108.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Riga Thomas JCIK 0001726378 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −69,389 | $0.54 | −$37,470.06 | 2,008,022 | Direct | |
| Jan 31, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −107,424 | $0.66F2 | −$70,899.84 | 1,900,598 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices that when rounded to the nearest cent were equal to $0.66. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.